- Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.
Basal insulin such as Levemir is a type of long-acting insulin injected once or twice a day as opposed to rapid, short, or intermediate-acting insulin. It is often used by people with Type 1 diabetes and sometimes by people with Type 2.Novo, which overtook LVMH as Europe's most valuable listed company this year, posted record operating profit for the third quarter, with sales of its obesity drug Wegovy reaching $1.36 billion, up 28% from the previous quarter.
Thousands of people are reportedly lining up to have a portion of their skull removed and one of Elon Musk's brain chips implanted
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Источник: YahooFinanceCA - 🏆 47. / 63 Прочитайте больше »
Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Источник: YahooFinanceCA - 🏆 47. / 63 Прочитайте больше »
Factbox-How Huawei plans to rival Nvidia in the AI chip businessU.S. curbs on the sales of advanced artificial chips by Nvidia to China are creating an opening for Huawei to win market share, with sources saying it won a ...
Источник: YahooFinanceCA - 🏆 47. / 63 Прочитайте больше »
Emerging market currencies to claw back ground in 2024 as dollar fades: Reuters pollEmerging market currencies will take well into next year to start making noticeable gains against a retreating U.S. dollar, despite a growing view the...
Источник: YahooFinanceCA - 🏆 47. / 63 Прочитайте больше »
Embraer hopeful E2 jets can break into U.S. market, CEO saysBrazilian planemaker Embraer has been trying to sell U.S. carriers on the merits of its E195-E2 jet as a 'small narrow-body', even as demand in its No.1...
Источник: YahooFinanceCA - 🏆 47. / 63 Прочитайте больше »